United Kingdom · Ageing Society, Health & Nutrition
Glycos Biomedical Ltd
Glycos Biomedical Ltd is a UK early-stage company with 1 public funding or programme announcement on record, most recently 1 May 2025.
Announcements
Innovate UK funding awarded
£337,019 · Collaborative R&D grant; “Development of GBM-1511: A Novel Heparinoid Therapy Targeting Sepsis-Induced Endotheliopat”; London
Is this your company?
Everything here comes from the public announcement or open dataset linked above. If something is wrong or out of date, or you would rather not be listed, email hello@capitalsignals.uk.
Not a recommendation
Support or selection by Innovate UK is not a sign that the company is a good investment. Most early-stage companies cannot be invested in by the public, and many fail.